Maury Raycroft
Stock Analyst at Jefferies
(1.60)
# 3,425
Out of 5,182 analysts
59
Total ratings
35.56%
Success rate
-2.13%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $32 → $43 | $37.59 | +14.39% | 4 | Feb 3, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $66 → $81 | $87.39 | -7.31% | 3 | Feb 2, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $114 → $63 | $24.10 | +161.41% | 1 | Dec 30, 2025 | |
| MREO Mereo BioPharma Group | Downgrades: Hold | $7 → $0.5 | $0.29 | +72.41% | 2 | Dec 30, 2025 | |
| CELC Celcuity | Maintains: Buy | $108 → $134 | $121.03 | +10.72% | 2 | Dec 2, 2025 | |
| AUPH Aurinia Pharmaceuticals | Upgrades: Buy | $10 → $21 | $15.98 | +31.41% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Downgrades: Hold | $2 → $1.6 | $1.23 | +30.08% | 1 | Oct 31, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $550 → $549 | $305.54 | +79.68% | 4 | Oct 30, 2025 | |
| KZR Kezar Life Sciences | Downgrades: Hold | $18 → $7 | $7.33 | -4.50% | 2 | Oct 17, 2025 | |
| KOD Kodiak Sciences | Initiates: Buy | $15 | $44.84 | -66.55% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $3.5 | $1.72 | +103.49% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $53 | $10.06 | +426.84% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $5.03 | +59.05% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.19 | +1,478.12% | 1 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $21.49 | -72.08% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $25.77 | -26.27% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $15 | $3.70 | +305.41% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $17.70 | -66.09% | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $1.50 | +1,433.33% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $195 | $1.79 | +10,793.85% | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $8.94 | +23.04% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $6 | $37.69 | -84.08% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $75 | $73.91 | +1.47% | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.10 | +254.84% | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $38 → $5 | $1.71 | +193.26% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $5.50 | +554.55% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $105 | $7.92 | +1,225.76% | 1 | May 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $172 | $48.79 | +252.57% | 2 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.97 | +1,482.49% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $13.63 | +208.14% | 3 | Nov 1, 2017 |
Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $37.59
Upside: +14.39%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66 → $81
Current: $87.39
Upside: -7.31%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114 → $63
Current: $24.10
Upside: +161.41%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7 → $0.5
Current: $0.29
Upside: +72.41%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108 → $134
Current: $121.03
Upside: +10.72%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10 → $21
Current: $15.98
Upside: +31.41%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2 → $1.6
Current: $1.23
Upside: +30.08%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550 → $549
Current: $305.54
Upside: +79.68%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18 → $7
Current: $7.33
Upside: -4.50%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $44.84
Upside: -66.55%
Jun 24, 2025
Initiates: Hold
Price Target: $3.5
Current: $1.72
Upside: +103.49%
Mar 11, 2025
Maintains: Buy
Price Target: $70 → $53
Current: $10.06
Upside: +426.84%
Feb 10, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $5.03
Upside: +59.05%
Dec 31, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.19
Upside: +1,478.12%
Nov 18, 2024
Initiates: Buy
Price Target: $6
Current: $21.49
Upside: -72.08%
Jul 17, 2024
Initiates: Buy
Price Target: $19
Current: $25.77
Upside: -26.27%
May 7, 2024
Assumes: Buy
Price Target: $23 → $15
Current: $3.70
Upside: +305.41%
Mar 13, 2024
Initiates: Buy
Price Target: $6
Current: $17.70
Upside: -66.09%
Mar 5, 2024
Initiates: Buy
Price Target: $23
Current: $1.50
Upside: +1,433.33%
Feb 8, 2024
Initiates: Buy
Price Target: $195
Current: $1.79
Upside: +10,793.85%
Aug 4, 2023
Upgrades: Buy
Price Target: $11
Current: $8.94
Upside: +23.04%
Jan 4, 2023
Downgrades: Hold
Price Target: $32 → $6
Current: $37.69
Upside: -84.08%
Nov 29, 2022
Maintains: Buy
Price Target: $92 → $75
Current: $73.91
Upside: +1.47%
Sep 12, 2022
Initiates: Buy
Price Target: $11
Current: $3.10
Upside: +254.84%
Dec 2, 2021
Downgrades: Hold
Price Target: $38 → $5
Current: $1.71
Upside: +193.26%
Jun 1, 2021
Initiates: Buy
Price Target: $36
Current: $5.50
Upside: +554.55%
May 27, 2021
Initiates: Buy
Price Target: $105
Current: $7.92
Upside: +1,225.76%
Apr 21, 2021
Upgrades: Buy
Price Target: $172
Current: $48.79
Upside: +252.57%
Feb 24, 2020
Initiates: Buy
Price Target: $47
Current: $2.97
Upside: +1,482.49%
Nov 1, 2017
Maintains: Buy
Price Target: $36 → $42
Current: $13.63
Upside: +208.14%